Published in TB and Outbreaks Week, June 3rd, 2008
"We were very pleased with the rapid response to treatment, and we had the opportunity to observe the excellent clinical response ourselves," said Eugene Seymour, MD, MPH, CEO of the Company. "The clinical results we observed are far superior to any data reported in the literature," said Anil R. Diwan, PhD, President of the Company.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week